Chakraborty , Pallab, and Kaustav Chakraborty. “Anti-Fibrotic Agents Could Be the Game-Changer for Post-COVID-19 Pulmonary Fibrosis Treatment”. European Journal of Biological Research 12, no. 1 (January 1, 2022): 1–10. Accessed April 20, 2024. http://jbrodka.com/index.php/ejbr/article/view/1.